Hy-Gro Chemicals Pharmtek is an API manufacturer based in India. It holds 4 active US drug master files across a filed portfolio of 3 molecules. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 22 May 2025 as VAI. Customs aggregates show $21.6M of exports covering 259 molecules to 30 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Medak, India | 3009609117 |
| Hyderabad, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Dextromethorphan | US FDA | 2 |
| Doxylamine | US FDA | 2 |
| Flurbiprofen | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.6M | 16 |
| 2025 | Not reported | $21.6M | 30 |
| 2024 | Not reported | $22.7M | 30 |
| 2023 | Not reported | $25.6M | 34 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Hy-Gro Chemicals Pharmtek, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.